These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3875804

  • 41. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
    Youngster SK, Nicklas WJ, Heikkila RE.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):829-35. PubMed ID: 2786565
    [Abstract] [Full Text] [Related]

  • 42. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Nature; 1989 Jun; 327(6120):324-6. PubMed ID: 2884568
    [Abstract] [Full Text] [Related]

  • 43. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Jun; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 44. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. The role of MAO in MPTP toxicity--a review.
    Glover V, Gibb C, Sandler M.
    J Neural Transm Suppl; 1986 Nov; 20():65-76. PubMed ID: 3091762
    [Abstract] [Full Text] [Related]

  • 49. Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivo.
    Corsini GU, Bocchetta A, Zuddas A, Piccardi MP, Del Zompo M.
    Biochem Pharmacol; 1988 Nov 01; 37(21):4163-9. PubMed ID: 3263863
    [Abstract] [Full Text] [Related]

  • 50. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
    Lydén-Sokolowski A, Larsson BS, Lindquist NG.
    Pharmacol Toxicol; 1988 Aug 01; 63(2):75-80. PubMed ID: 3141911
    [Abstract] [Full Text] [Related]

  • 51. Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates.
    Kalgutkar AS, Castagnoli K, Hall A, Castagnoli N.
    J Med Chem; 1994 Apr 01; 37(7):944-9. PubMed ID: 8151621
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicity.
    Willoughby J, Glover V, Sandler M, Albanese A, Jenner P, Marsden CD.
    Neurosci Lett; 1988 Jul 19; 90(1-2):100-6. PubMed ID: 3137508
    [Abstract] [Full Text] [Related]

  • 54. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sayre LM.
    Toxicol Lett; 1989 Aug 19; 48(2):121-49. PubMed ID: 2672418
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Localization of MPP+ binding sites in the brain of various mammalian species.
    Del Zompo M, Piccardi MP, Ruiu S, Albanese A, Morelli M.
    J Neural Transm Park Dis Dement Sect; 1992 Aug 19; 4(3):181-90. PubMed ID: 1627253
    [Abstract] [Full Text] [Related]

  • 57. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO, Malan SF, Terre'Blanche G, Castagnoli K, Castagnoli N, Bergh JJ, Petzer JP.
    Life Sci; 2007 Jul 19; 81(6):458-67. PubMed ID: 17655878
    [Abstract] [Full Text] [Related]

  • 58. Age-dependent effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): correlation with monoamine oxidase-B.
    Walsh SL, Wagner GC.
    Synapse; 1989 Jul 19; 3(4):308-14. PubMed ID: 2787063
    [Abstract] [Full Text] [Related]

  • 59. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopamine synthesis and release in the rabbit retina in vitro.
    Ofori S, Schorderet M.
    Neuropharmacology; 1987 Nov 19; 26(11):1607-10. PubMed ID: 3501550
    [Abstract] [Full Text] [Related]

  • 60. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.
    Synapse; 1999 Jun 01; 32(3):153-64. PubMed ID: 10340626
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.